<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bonumose on Bioecon</title><link>https://en.bioecon.ru/companies/bonumose/</link><description>Recent content in Bonumose on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 07 Jul 2026 00:01:46 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/bonumose/index.xml" rel="self" type="application/rss+xml"/><item><title>Rare sugars and enzymatic sweeteners</title><link>https://en.bioecon.ru/technology/rare-sugars-enzymatic-sweeteners/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/rare-sugars-enzymatic-sweeteners/</guid><description>Enzymatic epimerization turns commodity starch and fructose into allulose and tagatose — naturally occurring low-calorie sugars with sugar-like taste — while a separate fermentation route delivers stevia-derived sweeteners, moving allulose from &amp;lsquo;unicorn ingredient&amp;rsquo; to commercial reality.</description></item></channel></rss>